The ACADSB gene helps your body break down isoleucine, a building block from protein, and certain branched fats so cells can use them for energy. This gene plays an important role in how your cells handle fuel between meals and during illness. If the ACADSB gene does not work properly, these substances can build up and cause short/branched chain acyl-CoA dehydrogenase deficiency. Many people found through newborn screening stay well, while some may have low energy, poor feeding, vomiting, or episodes of low blood sugar.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate what happens in the body. Some genes provide the directions for producing proteins, which do much of the cell’s work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. More detail on this topic is available in the LearnHub.
Overview
ACADSBGene function
What if the gene works
The ACADSB gene helps your cells break down certain fats and the amino acid isoleucine for energy. Its protein works in mitochondria, the parts of cells that help supply energy.
Risk
What if the gene does not work
Changes in the ACADSB gene can cause SBCAD deficiency, which affects how the body breaks down some amino acids. Many people have no symptoms, while others may have vomiting, tiredness, or developmental delay; milder and severe variants can differ.
Treatment
What does that mean for your treatment
No ACADSB-specific treatment or drug-choice approach is currently established. When care is needed, it usually centers on general metabolic support during illness, such as avoiding prolonged fasting, rather than a targeted medicine.
Conditions associated with ACADSB
Gene function
What if the gene works
Your cells need steady ways to turn food into energy. The ACADSB gene helps mitochondria, the parts of cells that make energy, process certain small fuel pieces that come from protein and fat. This supports smooth day to day energy handling in many tissues.
The ACADSB gene helps your cells break down part of isoleucine, an amino acid from food. This helps mitochondria break down isoleucine for energy in a stepwise way.
Its protein works on short, branched fuel molecules made as your body processes some fats and proteins. This keeps those fuel pieces moving through the energy pathway in an orderly sequence.
ACADSB works inside mitochondria, the parts of cells that make most usable energy. It carries out an early chemical step so other enzymes can continue the job.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
ACADSB gene variants can change the enzyme’s shape, stability, or ability to reach the cell’s energy centers, so its activity is reduced or lost. Some variants leave partial function, while more disruptive variants can result in little or no working protein. In SBCADD, this range in functional effect may help explain why some people are found only on newborn screening, while others have earlier or more noticeable features.
How variants are linked to conditions
Pathogenic variants in the ACADSB gene cause short/branched-chain acyl-CoA dehydrogenase deficiency, also called 2-methylbutyrylglycinuria. This is the main ACADSB gene condition described in human genetics. It is often picked up on newborn screening, and many people remain well, while some may have poor feeding, vomiting, low energy, developmental delay, or seizures. A confirmed disease-causing variant in the ACADSB gene can support or establish the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are a routine feature of human biology and are widespread in the general population. Most do not directly affect health and simply reflect natural human variation. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental influences play a role. In contrast, there are cases in which a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ACADSB, risk is mainly shaped by inheritance: a child is affected when both parents pass on a harmful ACADSB change, so family history and having carrier parents matter most. In someone who already has this condition, long fasting, infections, or other physical stress can make symptoms more likely.
Inheritance of ACADSB variants
ACADSB-related conditions are inherited in an autosomal recessive pattern. In practical terms, how ACADSB gene variants are inherited usually means a person develops the condition only when they receive one altered copy from each parent. Parents who each carry one ACADSB gene variant are typically unaffected carriers, and with each pregnancy there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy. This pattern is the well-established inheritance model for ACADSB deficiency.
What does my ACADSB result mean for my family?
Changes in the ACADSB gene are linked to a rare inherited condition that usually runs in families in a recessive pattern. This often means parents may be healthy carriers, and brothers or sisters could also have the condition or be carriers. Other relatives, such as adult siblings, may also want to learn whether they carry the family’s ACADSB change.
Genetic information
Genetic testing
How you find out about variants
Variants in the ACADSB gene are found with genetic testing, usually from a blood sample or cheek swab. In ACADSB genetic testing, a lab reads the gene’s DNA code to look for changes and may compare results with symptoms and other test findings. Results can show a disease-causing variant, a benign variant, or an unclear finding.
When should I consider getting a genetic test?
Consider genetic testing for the ACADSB gene if newborn screening suggests a problem breaking down certain protein building blocks, if a child has repeated vomiting or unusual sleepiness during illness, or if this condition runs in the family. Testing can help confirm whether ACADSB changes are the cause.
A genetic result is only one part of your health story
Genetic test findings can provide useful information, but how much they reveal varies by the condition and the specific type of variant. Many factors, including age, environment, lifestyle, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a medication more slowly or more quickly than others, which can change how well it works or how likely side effects are. This kind of difference is common and helps explain why the same treatment can feel very effective for one person but less helpful or harder to tolerate for another.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences can affect the way a person responds to medicines. It looks at gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. Understanding this can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the ACADSB gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used. If you have questions about side effects, supplements, or how a health condition may affect treatment, talk with your doctor or pharmacist.
History
In recent decades, awareness of the ACADSB gene’s role has grown through research on rare inherited metabolic conditions. Scientists first recognized the related enzyme deficiency through unusual chemical patterns found in blood and urine, before the ACADSB gene itself was clearly defined. From these first observations, research expanded steadily, and pathogenic variants in the ACADSB gene were linked to 2-methylbutyrylglycinuria. As genetic testing improved, clinicians could connect these lab findings to a specific inherited cause. Expanded newborn screening also brought more attention to ACADSB, because some babies were identified before symptoms appeared. This history helped move ACADSB from a biochemical clue to a clearly recognized gene in clinical genetics.